Management of Tamaka Swasa with special reference to Bronchial Asthma with Kulattha Guda

Phase 2

Not yet recruiting

• Conditions: Health Condition 1: J454- Moderate persistent asthma

• Registration Number: CTRI/2024/07/069912
• Lead Sponsor: Dr Lopamudra Bag

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients having classical symptoms of Tamaka swasa Viz. Swasakruchhata (Dyspnoea), Rudhha Ghurghurakam(Wheezing),Urahpida(Chest tightness),

Peenasa(Rhinitis) etc.

Exclusion Criteria

Other diseases like Left ventricular failure, COPD, Upper respiratory tract obstruction, Bronchiectasis, Cases of Tuberculosis, occupational lungs disease, Tropical pulmonary eosinophilia, etc

Patient who need salbutamol inhaler daily

Diabetes mellitus and hypertension

Pregnant or lactating mother

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To reduce the classical symptoms of Tamaka Swasa like dyspnoea, wheezing, chest tightness, rhinitis etc.Timepoint: 30days

Secondary Outcome Measures

Name	Time	Method
To reduce chest tightness & running noseTimepoint: 30days